Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$25.43 +0.08 (+0.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Amphastar Pharmaceuticals (AMPH) Gross Profit (2013 - 2026)

Updated

Amphastar Pharmaceuticals' Gross Profit was $93.47 million in Q2 2026, up 8.1% from $86.49 million a year earlier and up 32.9% from the prior quarter.

Analysis

Amphastar Pharmaceuticals (AMPH) Gross Profit (2013 - 2026) Analysis & Trends

On a trailing twelve-month basis, Amphastar Pharmaceuticals' Gross Profit was $348.11 million through Jun 30, 2026, down 3.4% year-over-year; for FY2025, it came in at $356.06 million, down 4.8% from FY2024.

  • Gross Profit shows a five-year compound annual growth rate of 20.0% (FY2020 to FY2025).
  • In earlier years, Gross Profit was $373.86 million in FY2024 (+6.5%), $351.12 million in FY2023 (+41.1%), $248.86 million in FY2022 (+24.6%) and $199.74 million in FY2021 (+39.3%).
  • Quarterly Gross Profit has moved between $51.18 million (Q3 2021) and $108.4 million (Q3 2023) over five years.
  • Compared with a year earlier, Gross Profit was higher in 1 of the last eight quarters, with an average decline of 5.5%.
  • The best year-over-year quarter for Gross Profit over five years was Q3 2023 (growth of 85.3%); the worst was Q1 2026 (a decline of 17.5%).
  • Per Business Quant data, AMPH's Gross Profit in the three quarters before Q2 2026 was $70.32 million (Q1 2026), $85.67 million (Q4 2025) and $98.65 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Amphastar Pharmaceuticals 1.08 Bn -59.50 Mn 93.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 93.47 Mn
Mar 31, 2026 70.32 Mn
Dec 31, 2025 85.67 Mn
Sep 30, 2025 98.65 Mn
Jun 30, 2025 86.49 Mn
Mar 31, 2025 85.25 Mn
Dec 31, 2024 86.65 Mn
Sep 30, 2024 101.94 Mn
Jun 30, 2024 95.17 Mn
Mar 31, 2024 90.10 Mn
Dec 31, 2023 96.14 Mn
Sep 30, 2023 108.40 Mn
Jun 30, 2023 72.74 Mn
Mar 31, 2023 73.84 Mn
Dec 31, 2022 71.17 Mn
Sep 30, 2022 58.51 Mn
Jun 30, 2022 63.36 Mn
Mar 31, 2022 55.83 Mn
Dec 31, 2021 56.23 Mn
Sep 30, 2021 51.18 Mn
API Access

Amphastar Pharmaceuticals Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=AMPH&period=max&api_key=YOUR_API_KEY